tiprankstipranks
Trending News
More News >
Milestone Pharmaceuticals (MIST)
NASDAQ:MIST
US Market

Milestone Pharmaceuticals (MIST) Income Statement

Compare
708 Followers

Milestone Pharmaceuticals Income Statement

Last quarter (Q3 2025), Milestone Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Milestone Pharmaceuticals's net income was $-11.92M. See Milestone Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 1.00M$ 5.00M$ 15.00M$ 0.00
Gross Profit
$ 0.00$ 1.00M$ 5.00M$ 15.00M$ 0.00
Operating Expenses
$ 42.10M$ 62.10M$ 64.64M$ 58.07M$ 50.71M
Depreciation and Amortization
$ 105.00K$ 92.00K$ 89.00K$ 93.00K$ 97.00K
EBITDA
$ -37.83M$ -57.04M$ -58.30M$ -42.98M$ -50.61M
Operating Income
$ -42.10M$ -61.10M$ -59.64M$ -43.07M$ -50.71M
Other Income/Expenses
$ 583.00K$ 1.41M$ 1.25M$ 220.00K$ 726.00K
Pretax Income
$ -41.52M$ -59.69M$ -58.39M$ -42.85M$ -49.98M
Net Income
$ -41.52M$ -59.69M$ -58.39M$ -42.85M$ -49.97M
Per Share Metrics
Basic EPS
$ -0.67$ -1.39$ -1.35$ -1.02$ -1.70
Diluted EPS
$ -0.67$ -1.39$ -1.35$ -1.02$ -1.70
Weighted Average Shares Outstanding
62.21M 42.96M 42.45M 41.83M 29.34M
Weighted Average Shares Outstanding (Diluted)
62.21M 42.96M 42.45M 41.83M 29.34M
Currency in USD

Milestone Pharmaceuticals Earnings and Revenue History